UNSPSC 51282520: Cefadroxil hemihydrate

This classification denotes a cephalosporin antibiotic with the molecular formula 2C16H17N3O5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J9CMF6461M, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6r-(6alpha,7beta(r*)))- but more generally known as cefadroxil hemihydrate, which bears US NIH Compound Identifier 47964. Most nations, for tariff and trade purposes, schedule cefadroxil hemihydrate under HS 29419000 and SITC 54139.

UNSPSC 51282520 Cefadroxil hemihydrate is a Commodity code that in practice spans pharmaceutical procurement for state and local health systems, emergency services, and cooperative purchasing programs — though recent solicitations show the code captures a much broader range of pharmaceutical and medical supply acquisition than the narrow antibiotic product name suggests. State and local governments use this code to solicit everything from emergency naloxone and drug deactivation systems to multi-state generic pharmaceutical contracts and first-aid supplies for fire rescue operations. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), cities (Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), reflecting the diversity of end-users and procurement vehicles in state and local pharmaceutical supply.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building; the City of Tampa's sealed-bid procurement 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the fire rescue division, estimated at $700,000 and designated as a sheltered market for certified small local business enterprises with a 5% bid discount; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities; and the Minnesota Department of Administration's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers across participating state and local facilities in Minnesota and Oregon.